Repurposing azacitidine and carboplatin to prime immune checkpoint blockade-resistant melanoma for anti-PD-L1 re-challenge
Article in Cancer Research Communications (August 2022)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Cancer Research Communications (August 2022)
Preprint in medRxiv (February 2022)
Article in Cancers (April 2021)